Who owns the CX CANCERVAX trademark?

The CX CANCERVAX trademark is owned by CancerVAX, Inc..

What class is the CX CANCERVAX trademark registered in?

The CX CANCERVAX trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CX CANCERVAX?

The USPTO serial number for CX CANCERVAX is 97777928.

What is the registration number for CX CANCERVAX?

CX CANCERVAX is registered under USPTO registration number 7417641.

Sealvo

Home Search: CX CANCERVAXCX CANCERVAX #97777928

Back

Updated Oct 1, 2026·17 searches this week

View on USPTO TSDR Find similar marks

CXC

USPTO Trademark Record

REGISTERED

CX CANCERVAX

SN 97777928·Reg 7417641·Filed Feb 02, 2023

Owner CancerVAX, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CX CANCERVAX (Serial No. 97777928), Registration No. 7417641, is a registered US trademark filed on Feb 02, 2023 by CancerVAX, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: June 18, 2030

Conflict Analysis

Full conflict analysis for CX CANCERVAX (SN 97777928) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CX CANCERVAX (Reg. #7417641) is a registered US trademark that has been protecting its owner, CancerVAX, Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 02, 2023

SERIAL

97777928

REG#

7417641

REGISTERED

Jun 18, 2024

Filing Information

StatusREGISTERED

Filing DateFeb 02, 2023

Serial Number97777928

Registration No.7417641

Registration DateJun 18, 2024

Status DateJun 18, 2024

Published for OppositionApr 02, 2024

Filing Basis & Declarations

Filed as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 27, 2022

First use in commerce: Sep 27, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

18 events

REGISTERED-PRINCIPAL REGISTER

Jun 18, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 18, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 13, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 13, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 13, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

PUBLISHED FOR OPPOSITION

Apr 02, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 02, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 13, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 26, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 07, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 06, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 06, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 13, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 13, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 13, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 31, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 21, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 07, 2023

NEW APPLICATION ENTERED

Other Marks by CancerVAX, Inc.

Additional USPTO filings from the same owner.

97777942

CancerVAX, Inc.

REGISTERED

CAN

CANCERVAX

97777914

CancerVAX, Inc.

REGISTERED

CAN

CANCERVAX

90752328

CancerVAX, Inc.

REGISTERED

CAN

CAN-VAX

75942451

CancerVax, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CAN

CANCERVAX

97777914

CancerVAX, Inc.

REGISTERED

CAN

CANCERVAX

90752328

CancerVAX, Inc.

REGISTERED

88290085

CommerceCX, Inc.

REGISTERED

99125644

SponsorCX, Inc.

REGISTERED

Other Marks by Jeffery M. Lillywhite

Additional USPTO filings handled by the same attorney of record.

ZEN

ZENWOODS

99097411

REGISTERED

JAS

JASE CASE

99001578

REGISTERED

YOU

YOU COULD BE HERE!

99415679

REGISTERED

OWN

OWNER TRAUMA

98434919

REGISTERED

CX CANCERVAX

Run a conflict check

Other Marks by CancerVAX, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jeffery M. Lillywhite

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company